Throat Exerciser for Swallowing Disorders
Trial Summary
What is the purpose of this trial?
The goal of this a clinical trial is to test the effect of a pharyngeal exerciser in rehabilitation of pharyngeal phase of swallowing in patients with dysphagia. The main question it aims to answer is: •Does application of pharyngeal exerciser improve swallowing as evidenced by need for prescribed intervention for dysphagia (maneuvers, exercises or dietary modification to prevent aspiration). Participants will: * Perform barium swallows in lateral view fluoroscopy * Over a six-week period, perform thrice daily sessions of swallowing with an external, laryngeal restriction device covering the larynx * Return for another fluoroscopic barium swallow study
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Pharyngeal Exerciser for swallowing disorders?
The research on virtual reality rehabilitation and gamification for physical therapy suggests that engaging and motivating treatment methods can improve patient adherence and outcomes, which may indirectly support the use of innovative devices like the Pharyngeal Exerciser for swallowing disorders.12345
Is the Throat Exerciser for Swallowing Disorders safe for humans?
How is the Pharyngeal Exerciser treatment different from other treatments for swallowing disorders?
The Pharyngeal Exerciser is unique because it focuses on strengthening the muscles involved in swallowing through a specific exercise device, which is different from other treatments that may involve general exercises or medications. This device targets the pharyngeal muscles directly, potentially offering a more targeted approach to improving swallowing function.6891011
Research Team
Reza Shaker, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for healthy adults over 65 with swallowing difficulties, who have pharyngeal residue seen on a fluoroscopic study and are undergoing treatment to improve swallowing. It's not for those with cognitive impairments, muscle diseases, allergies to lidocaine or barium, neuro-muscular junction disorders, pregnant or lactating women, anyone unable to use the device independently or under 18.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline functional outcome assessment of swallowing (FOAMS) and fluoroscopic barium swallow study
Treatment
Participants perform thrice daily sessions of swallowing with an external, laryngeal restriction device over a six-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment, including follow-up fluoroscopic study and functional outcome assessment
Open-label extension (optional)
Participants in the sham group may opt into another 6 weeks of pharyngeal exercise using the pharyngeal exerciser
Treatment Details
Interventions
- Pharyngeal Exerciser (Behavioural Intervention)
- Sham Pharyngeal Exerciser (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor
Dr. Joseph E. Kerschner
Medical College of Wisconsin
Chief Medical Officer since 2011
MD, specific institution not identified
Dr. John R. Raymond, Sr.
Medical College of Wisconsin
Chief Executive Officer since 2010
MD from the Medical University of South Carolina